Colorectal
CA266-0003
A randomized Phase 2/3 Study of BMS-986545 (BNT327) in combination with chemotherapy versus bevacizumab in combination with chemotherapy in participants with previously untreated unresectable, recurrent, or metastatic colorectal cancer.
Trial overview
Clinical Area
Medical Oncology
Disease
Colorectal
Disease site
Gastrointestinal (GI)
Study Phase
II
Trial Identifiers
Registration number: NCT07221357
GenesisCare Location(s)
Principal Investigator(s)